Wilmington, Delaware, Oct. 03, 2024 (GLOBE NEWSWIRE) -- Allied Market Research published a report, titled, "Bilirubin Meters Market by Product (Bench-Top and Transcutaneous), Indication (Jaundice and Hepatitis), Age Group (Neonatal and Adults), and End User (Hospitals and Nursing Home, Clinics and Others): Global Opportunity Analysis and Industry Forecast, 2024-2033". According to the report, the bilirubin meters market was valued at $1.2 billion in 2023, and is estimated to reach $2.5 billion by 2033, growing at a CAGR of 7.6% from 2024 to 2033.
Request Sample of the Report on Bilirubin Meters Market 2033 - https://www.alliedmarketresearch.com/request-sample/A324070
Prime Determinants of Growth
The market for bilirubin meters is primarily driven by the increasing prevalence of neonatal jaundice and the rising awareness about early diagnosis and treatment of hyperbilirubinemia. Neonatal jaundice is a common condition among newborns, characterized by high levels of bilirubin in the blood, leading to yellowing of the skin and eyes. Early detection and management are crucial to prevent severe complications such as kernicterus, which can cause irreversible neurological damage. Thus, the rise in prevalence of neonatal jaundice is expected to contribute significantly in the growth of the market.
Technological advancements in bilirubin meters are also contributing significantly to market growth. Modern bilirubin meters are equipped with features such as portability, ease of use, and high accuracy, making them preferable over traditional laboratory methods. These devices often utilize transcutaneous measurement techniques, reducing the need for blood samples and minimizing discomfort for newborns. The integration of digital technologies and data management systems further enhances their utility in clinical settings, allowing for better patient monitoring and record-keeping. Thus, the technological advancement in the bilirubin meters is expected to drive the growth of the market.
Report Coverage & Details
| Repot Coverage | Details |
| Forecast Period | 2024–2033 |
| Base Year | 2023 |
| Market Size in 2023 | $1.2 billion |
| Market Size in 2033 | $2.5 billion |
| CAGR | 7.6% |
| No. of Pages in Report | 280 |
| Segments Covered | Product, Indication, Age Group, End User and Region |
| Drivers |
|
| Opportunities |
|
| Restraint |
|
Want to Explore More, Connect to our Analyst - https://www.alliedmarketresearch.com/connect-to-analyst/A324070
Segment Highlights
The transcutaneous segment dominated market share in 2023
By product, transcutaneous segment dominated the market share in 2023. This is attributed to the fact that transcutaneous bilirubin meters offer a non-invasive method for measuring bilirubin levels, which is particularly advantageous in neonatal care. This non-invasive approach reduces the risk of infection and discomfort associated with blood draws, making it a preferred choice for both healthcare providers and parents. Additionally, advancements in technology have improved the accuracy and reliability of transcutaneous bilirubin meters, making them comparable to traditional blood tests.
Jaundice segment dominated the market share in 2023
By indication, jaundice segment dominated the market share in 2023. This is attributed to jaundice, which is a common condition, especially in newborns, where bilirubin levels in the blood are elevated, leading to yellowing of the skin and eyes. The high prevalence of neonatal jaundice, which affects approximately 60% of full-term and 80% of preterm infants, necessitates frequent monitoring and accurate diagnosis. Bilirubin meters provide a non-invasive, efficient, and reliable method for this purpose, making them essential tools in neonatal care.
Neonatal segment dominated market share in 2023
By age group, neonatal segment dominated the market share in 2023. This is attributed to the fact that Newborns, particularly those born prematurely, are highly susceptible to jaundice, a condition characterized by high levels of bilirubin in the blood. Jaundice in neonates is a common and significant clinical concern that requires prompt and accurate diagnosis to prevent severe complications such as kernicterus, which can lead to permanent neurological damage. Consequently, there is a high demand for reliable and non-invasive bilirubin meters to monitor bilirubin levels in neonates.
Hospitals and Nursing Home segment dominated market share in 2023
By end user, hospitals and nursing home segment dominated the market share in 2023. This is attributed to the fact that healthcare facilities routinely handle a significant number of neonatal patients, who are particularly susceptible to jaundice and other bilirubin-related conditions. The need for immediate and precise bilirubin level measurements in newborns drives the adoption of bilirubin meters, ensuring timely and appropriate treatment. Furthermore, the rise in the global birth rate, coupled with increased awareness of neonatal care, has intensified the demand for bilirubin meters in hospitals and nursing homes. These facilities also benefit from advanced healthcare infrastructure, which facilitates the integration of modern diagnostic technologies, including bilirubin meters. Additionally, the ongoing trend towards point-of-care testing in clinical settings has further propelled the use of portable and non-invasive bilirubin meters, enhancing the overall market growth within the hospital and nursing home subsegment.
For Purchase Related Queries/Inquiry - https://www.alliedmarketresearch.com/purchase-enquiry/A324070
Regional Outlook
North America holds a dominant position in the market, attributed to high adoption of the Bilirubin Meters, advanced healthcare infrastructure, supportive regulatory frameworks, and increasing prevalence of jaundice. In addition, the strong presence of major key players and high research and development activities in the region for development of advanced bilirubin meters is expected to contribute in the growth of the market. However, Asia-Pacific region is expected to register highest CAGR in the forecast period. This is attributed to technological advancements, high birth rate and developing healthcare infrastructure.
Key Players
- APEL Co. Ltd.
- Dragerwerk AG & Co. KGaA
- Mennen Medical Ltd.
- Micro Lab Instruments
- Ningbo David Medical Device Co. Ltd
- Siemens Healthineers AG
- Micro Labs Instruments
- AVI Healthcare Pvt Ltd
- F. Hoffmann-La Roche Ltd.
- Koninklijke Philips N.V
The report provides a detailed analysis of these key players in the global bilirubin meters market. The report is valuable in highlighting business performance, operating segments, product portfolio, and strategic moves of market players to showcase the competitive scenario
Trending Reports in Healthcare Industry:
3D Bioprinting in Medical Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Topical Pain Relief Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Peritoneal Dialysis Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
Optical Fibers in Endoscopy Market - Global Opportunity Analysis and Industry Forecast, 2023-2032
AVENUE- A Subscription-Based Library (Premium on-demand, subscription-based pricing model) Offered by Allied Market Research:
AMR introduces its online premium subscription-based library Avenue, designed specifically to offer cost-effective, one-stop solution for enterprises, investors, and universities. With Avenue, subscribers can avail an entire repository of reports on more than 2,000 niche industries and more than 12,000 company profiles. Moreover, users can get an online access to quantitative and qualitative data in PDF and Excel formats along with analyst support, customization, and updated versions of reports.
Get an access to the library of reports at any time from any device and anywhere. For more details, follow the link: https://www.alliedmarketresearch.com/library-access
About Allied Market Research:
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Wilmington, Delaware. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of "Market Research Reports" and "Business Intelligence Solutions." AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domains. AMR offers its services across 11 industry verticals including Life Sciences, Consumer Goods, Materials & Chemicals, Construction & Manufacturing, Food & Beverages, Energy & Power, Semiconductor & Electronics, Automotive & Transportation, ICT & Media, Aerospace & Defense, and BFSI.
We are in professional corporate relations with various companies and this helps us in digging out market data that helps us generate accurate research data tables and confirms utmost accuracy in our market forecasting. Allied Market Research CEO Pawan Kumar is instrumental in inspiring and encouraging everyone associated with the company to maintain high quality of data and help clients in every way possible to achieve success. Each and every data presented in the reports published by us is extracted through primary interviews with top officials from leading companies of domain concerned. Our secondary data procurement methodology includes deep online and offline research and discussion with knowledgeable professionals and analysts in the industry.
Contact
David Correa
1209 Orange Street,
Corporation Trust Center,
Wilmington, New Castle,
Delaware 19801 USA.
Toll Free: +1-800-792-5285
Int’l: +1-503-894-6022
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1-855-550-5975
Web: https://www.alliedmarketresearch.com
Follow Us on: LinkedIn Twitter
